The Company has created and continues to develop a rich pipeline of proprietary, flexible, delivery systems combined with the expertly formulated ingredients to deliver highly effective therapeutics to a precisely targeted area.
The Company's current focus is the Skin + CELL luxury skincare range. This range includes five products utilising our ground-breaking formulation and delivery expertise, to bring scientifically proven formulations to cosmetics. The company will continue to develop and expand on the dermatology formulation and delivery expertise for many areas of identified opportunity.
Originating from the Institute of Cancer Therapeutics ("ICT") at the University of Bradford, the Company has acquired and developed a portfolio of specific cancer-targeting therapeutics, with a strategy to develop each candidate from initial acquisition/discovery to commercially valuable partnerships at the earliest opportunity in its development pathway.
